Controversies over the role of radiation therapy for ductal carcinoma in situ

References

• Jemal A, Siegel R, Ward E et al. Cancer statistics, 2007. CA Cancer J. Clin.57(1), 43–66 (2007).
   PubMed Web of Science ®Google Scholar
• Page DL, Dupont WD, Rogers LW, Jensen RA, Schuyler PA. Continued local recurrence of carcinoma 15–25 years after a diagnosis of low grade ductal carcinoma in situ of the breast treated only by biopsy. Cancer76(7), 1197–1200 (1995).
   PubMed Web of Science ®Google Scholar
• Smith GL, Smith BD, Haffty BG. Rationalization and regionalization of treatment for ductal carcinoma in situ of the breast. Int. J. Radiat. Oncol. Biol. Phys.65(5), 1397–1403 (2006).
   PubMed Web of Science ®Google Scholar
• Baxter NN, Virnig BA, Durham SB, Tuttle TM. Trends in the treatment of ductal carcinoma in situ of the breast. J. Natl Cancer Inst.96(6), 443–448 (2004).
   PubMedGoogle Scholar
• Katz SJ, Lantz PM, Janz NK et al. Patterns and correlates of local therapy for women with ductal carcinoma-in-situ. J. Clin. Oncol.23(13), 3001–3007 (2005).
   PubMed Web of Science ®Google Scholar
• Fisher B, Land S, Mamounas E et al. Prevention of invasive breast cancer in women with ductal carcinoma in situ: an update of the national surgical adjuvant breast and bowel project experience. Semin. Oncol.28(4), 400–418 (2001).
   PubMed Web of Science ®Google Scholar
• Fisher ER, Dignam J, Tan-Chiu E et al. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) eight-year update of Protocol B-17: intraductal carcinoma. Cancer86(3), 429–438 (1999).
   PubMed Web of Science ®Google Scholar
• Bijker N, Meijnen P, Peterse JL et al. Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized Phase III trial 10853–a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. J. Clin. Oncol.24(21), 3381–3387 (2006).
   PubMed Web of Science ®Google Scholar
• Emdin SO, Granstrand B, Ringberg A et al. SweDCIS: Radiotherapy after sector resection for ductal carcinoma in situ of the breast. Results of a randomised trial in a population offered mammography screening. Acta Oncol.45(5), 536–543 (2006).
   PubMed Web of Science ®Google Scholar
• Ringberg A, Nordgren H, Thorstensson S et al. Histopathological risk factors for ipsilateral breast events after breast conserving treatment for ductal carcinoma in situ of the breast–results from the Swedish randomised trial. Eur. J. Cancer43(2), 291–298 (2007).
   Google Scholar
• Houghton J, George WD, Cuzick J et al. Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: randomised controlled trial. Lancet362(9378), 95–102 (2003).
   PubMed Web of Science ®Google Scholar
• Viani GA, Stefano EJ, Afonso SL et al. Breast-conserving surgery with or without radiotherapy in women with ductal carcinoma in situ: a meta-analysis of randomized trials. Radiat. Oncol.2, 28 (2007).
   Google Scholar
• Warren JL, Weaver DL, Bocklage T et al. The frequency of ipsilateral second tumors after breast-conserving surgery for DCIS: a population based analysis. Cancer104(9), 1840–1848 (2005).
   Google Scholar
• Smith BD, Haffty BG, Buchholz TA et al. Effectiveness of radiation therapy in older women with ductal carcinoma in situ. J. Natl Cancer Inst.98(18), 1302–1310 (2006).
   Google Scholar
• Silverstein MJ. An argument against routine use of radiotherapy for ductal carcinoma in situ. Oncology (Williston Park, NY),17(11), 1511–1533; discussion 1533–1514, 1539, 1542 passim (2003).
   Google Scholar
• Clarke M, Collins R, Darby S et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet366(9503), 2087–2106 (2005).
   PubMed Web of Science ®Google Scholar
• Ravdin PM, Siminoff IA, Harvey JA. Survey of breast cancer patients concerning their knowledge and expectations of adjuvant therapy. J. Clin. Oncol.16(2), 515–521 (1998).
   PubMed Web of Science ®Google Scholar
• Wong JS, Kaelin CM, Troyan SL et al. Prospective study of wide excision alone for ductal carcinoma in situ of the breast. J. Clin. Oncol.24(7), 1031–1036 (2006).
   PubMed Web of Science ®Google Scholar
• Fisher B, Costantino J, Redmond C et al. Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer. N. Engl. J. Med.328(22), 1581–1586 (1993).
   PubMed Web of Science ®Google Scholar
• Hughes L, Wang M, Page D et al. Five year results of intergroup study E5194: local excision alone (without radiation treatment) for selected patients with ductal carcinoma in situ (DCIS). Presented at: San Antonio Breast Cancer Symposium. San Antonio, TX, USA, 14–17 December (2006).
   Google Scholar
• Kerlikowske K, Molinaro A, Cha I et al. Characteristics associated with recurrence among women with ductal carcinoma in situ treated by lumpectomy. J. Natl Cancer Inst.95(22), 1692–1702 (2003).
   PubMedGoogle Scholar
• Silverstein MJ, Lagios MD, Groshen S et al. The influence of margin width on local control of ductal carcinoma in situ of the breast. N. Engl. J. Med.340(19), 1455–1461 (1999).
   PubMed Web of Science ®Google Scholar
• Macdonald HR, Silverstein MJ, Lee LA et al. Margin width as the sole determinant of local recurrence after breast conservation in patients with ductal carcinoma in situ of the breast. Am. J. Surg.192(4), 420–422 (2006).
   Google Scholar
• Wong ND, Thakral G, Franklin SS et al. Preventing heart disease by controlling hypertension: impact of hypertensive subtype, stage, age, and sex. Am. Heart J.145(5), 888–895 (2003).
   PubMed Web of Science ®Google Scholar
• Black DM, Cummings SR, Karpf DB et al. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group. Lancet348(9041), 1535–1541 (1996).
   PubMed Web of Science ®Google Scholar